HomeRLMD • NASDAQ
add
Relmada Therapeutics Inc
Nakaraang pagsara
$0.31
Sakop ng araw
$0.27 - $0.31
Sakop ng taon
$0.24 - $4.72
Market cap
9.63M USD
Average na Volume
368.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 19.08M | -28.90% |
Net na kita | -18.66M | 25.86% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 44.91M | -53.38% |
Kabuuang asset | 45.82M | -53.03% |
Kabuuang sagutin | 10.30M | -15.57% |
Kabuuang equity | 35.52M | — |
Natitirang share | 33.19M | — |
Presyo para makapag-book | 0.26 | — |
Return on assets | -93.93% | — |
Return on capital | -114.71% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -18.66M | 25.86% |
Cash mula sa mga operasyon | -8.80M | 14.15% |
Cash mula sa pag-invest | 11.35M | 46.56% |
Cash mula sa financing | -172.49K | -75.18% |
Net change in cash | 2.37M | 191.03% |
Malayang cash flow | -2.29M | -57.54% |
Tungkol
Headquarters
Website
Mga Empleyado
17
